Repligen | RGEN - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Agilent USD 282.7M 358K 2025-12
Align Technology USD 71.75M 736K 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Bruker USD 151.94M 225K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Danaher USD 706.9M 600K 2025-12
Dentsply International USD 199.5M 196.5M 2025-09
Exact Sciences USD 189.45M 232K 2025-09
General Electric Aerospace USD 1.05B 6.05M 2025-12
Henry Schein USD 115.77M 2.8M 2025-12
Illumina USD 152.8M 900K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.1M 0 2025-09
OraSure Technologies USD 0 0 2024-06
Pacific Biosciences Of California USD 258K 8K 2023-09
Pfizer USD 5.69B 1000K 2025-09
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Standard Biotools USD 383.61M 383.22M 2025-09
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Waters USD 98.08M 38.55M 2025-12
West Pharmaceutical Services USD 72M 100K 2025-12